Eye Movement Desensitization and Reprocessing (EMDR) for Police Personnel

Eye Movement Desensitization and Reprocessing (EMDR) for Stress, Psychological Trauma and Suicidal Ideation in Police Personnel: A Feasibility Randomised Controlled Trial

Objectives:

  1. To examine the feasibility of Eye Movement Desensitization and Reprocessing (EMDR) as an intervention to reduce psychological trauma and stress amongst police officers in Pakistan.
  2. To test whether reducing stress and psychological trauma reduces suicidal ideation in police officers.
  3. To explore participants' experiences with EMDR Intervention.

Study design and setting:

The study will be a mixed-method feasibility randomized controlled trial of EMDR as an intervention in treating symptoms such as stress, trauma and suicidal ideation in police officers. The study will be conducted in five major cities in Pakistan: Rawalpindi, Karachi, Peshawar, Quetta, and Lahore.

Sample size:

A total of N=80 eligible police officers will be recruited and randomized in the study.

Study Overview

Detailed Description

EMDR intervention is an evidence-based psychological intervention that has been proven effective for stress and trauma, however, research evidence on feasibility of EMDR in forensic settings in Pakistan is limited. The current study aims to establish the feasibility and acceptability of EMDR intervention for management of stress, psychological trauma and suicidal ideation amongst police officers in Pakistan. The study will recruit a total of 80 police officers from police stations in the participating study sites, and prospective participants will be screened against eligibility criteria. Eligible consented participants will be enrolled in the study. An independent statistician will randomize participants to one of the two study arms: 1) EMDR (Intervention); or 2) waiting list control arm. Each participant in the intervention arm will receive 8 individual, weekly EMDR sessions over 8 weeks. Each session will take approximately 60-90 minutes. The sessions will be delivered at a place convenient to the participants. Trained EMDR therapists will deliver the intervention. The waiting list control arm will receive their routine care as usual, As part of the safety protocol, the details of any services each participant receives in the control group will be obtained. EMDR treatment will be offered to the control group (waiting control group) after the active intervention is complete. Assessment measures will be administered before and after the intervention at 8th week. All assessments will be rater blind. After post-assessments at 8th week, a purposefully selected subset (stratified by age & gender) of participants will be invited for qualitative interviews to explore their experiences and satisfaction with the intervention. Participants will be interviewed within 1 week of their post-intervention by a trained qualitative researcher exploring their experience with EMDR, the barriers and facilitators to engagement, and perceived benefits or negative experiences with the intervention. A sample of up to 15 interviews would be enough to achieve category saturation. On average, interviews will last for 60 minutes. The interview will be face-to-face or through telephone as an alternative to a face-to-face meeting to reduce the number of in-person meetings given the current context of COVID-19.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Recruiting
        • Prison settings Peshawar
        • Contact:
          • Umair Ahsen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having suicidal ideation measured as a score > 2 on Beck scale of suicidal ideation
  • Aged 18 years - 60 years' old
  • Police officer with psychological trauma measured with the International Trauma Questionnaire and stress measured with stress subscale of Depression, Anxiety and Stress scale

Exclusion Criteria:

  • Less than 12 months' experience in the police officer.
  • Participants reporting active suicidal ideation measured as a score of 2 on item no 4 of BSSI will be excluded and referred to a psychiatric service.
  • With current history of use of hard/psychoactive substances (excluding tobacco and caffeine).
  • Unable to provide consent due to severe mental or physical illness.
  • Unlikely to be available for the entire duration of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EMDR receiving group
EMDR is a psychotherapeutic approach that emphasizes the role of the brain's information processing system in perfecting the psychological consequences of distressing events. EMDR is an eight-phase treatment protocol, including procedure that focuses on the memories underlying current problems and those that must be specifically addressed to bring the client to a robust state of psychological health. One of its distinguishing aspects is its use of bilateral physical stimulation, such as side-to-side eye movements, alternating hand taps, or alternating auditory tones while the person undergoing treatment is mentally focusing on aspects of various life experiences.
Each participant in the intervention group will receive 8 individual, weekly EMDR sessions over 8 weeks. Each session will take approximately 60-90 minutes. The sessions will be delivered at a place convenient to the participant. Trained EMDR therapists will deliver the intervention.
No Intervention: Waiting list Control Group
The control group will receive their routine care as usual. Once the trial is completed they will be invited for EMDR sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of recruitment
Time Frame: From baseline to 8th week (at the end of intervention)
The feasibility will be determined by collecting data on recruitment rates. The success criterion of feasibility will be to recruit > 50% of eligible participants.
From baseline to 8th week (at the end of intervention)
Acceptability measure
Time Frame: From baseline to 8th week (at the end of intervention)
Intervention acceptability will be assessed using data on intervention attendance. The criterion for acceptability is the intervention attendance rate of > 5 sessions.
From baseline to 8th week (at the end of intervention)
Feasibility of Retention
Time Frame: From baseline to 8th week (at the end of intervention)
The feasibility of retention will be determined by collecting data on retention rates. The success criterion of feasibility of retention will be to retain > 50% participants.
From baseline to 8th week (at the end of intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Scale for Suicide Ideation
Time Frame: Change in problem scores from baseline to 8th week
Beck Scale for Suicide Ideation is a 19-item instrument for detecting and measuring the current intensity of patient-specific attitude, behavior, and specificity of patient thoughts to kill themselves during the past week.
Change in problem scores from baseline to 8th week
The International Trauma Questionnaire
Time Frame: Change in problem scores from baseline to 8th week
The International Trauma Questionnaire is a brief, simple-worded measure focusing on the core features of post-traumatic stress disorder.
Change in problem scores from baseline to 8th week
Depression Anxiety and Stress Scale
Time Frame: Change in problem scores from baseline to 8th week
Depression Anxiety and Stress Scale is consist of three subscales that measure the negative emotional states of depression, anxiety, and stress and consist of 7 items per subscale. The participants are requested to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week.
Change in problem scores from baseline to 8th week
Beck Hopelessness Scale
Time Frame: Change in problem scores from baseline to 8th week
Beck hopelessness scale measure three aspects of hopelessness; feelings about the future, loss of motivation and expectations. The scale consists of 20 statements each of which is scored as 0 or 1.
Change in problem scores from baseline to 8th week
Sleep Quality Questionnaire
Time Frame: Change in problem scores from baseline to 8th week
Sleep Quality Questionnaire consists of eight items rated on a 5-point scale. It measures self-reported alertness, sleepiness, tiredness, and functional impairments associated with sleep and problems during waking hours within the past seven days.
Change in problem scores from baseline to 8th week
Coping Resource Inventory
Time Frame: Change in coping resources scores from baseline to 8th week
The Coping Resource Inventory assesses the individual's stress management and coping resources with stress.
Change in coping resources scores from baseline to 8th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Nasim Chahudhry, Pakistan Institute of Living and Learning
  • Principal Investigator: Nusrat Husain, University of Manchester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2022

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

December 11, 2021

First Submitted That Met QC Criteria

December 28, 2021

First Posted (Actual)

December 29, 2021

Study Record Updates

Last Update Posted (Actual)

May 17, 2024

Last Update Submitted That Met QC Criteria

May 16, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Eye Movement Desensitization and Reprocessing (EMDR)

3
Subscribe